Company news
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) news
Paradigm Biopharmaceuticals Ltd. news releases on 6ix. Latest, Mar 7, 2017: Paradigm Update Ross River Virus Clinical Trial
Press releases — page 5
Paradigm Update Ross River Virus Clinical Trial
March 7, 2017
Quarterly Cashflow Report
January 31, 2017
Recruitment complete in Paradigms hay fever clinical trial
January 24, 2017
Paradigms hay fever clinical trial cleared to commence
November 21, 2016
Appendix 4C - September 2016 quarter
October 28, 2016
Paradigms Placement heavily oversubscribed
October 17, 2016
Preclinical study underpins efficacy of Paradigms RhinosulR
September 15, 2016
Paradigm PPS a potential in the treatment of viral arthritis
September 6, 2016
Preliminary Final Report
August 31, 2016
Paradigm PPS nasal spray to treat Allergic Rhinitis
August 19, 2016
Shareholders Update
June 20, 2016